BOTULINUM TOXIN TREATMENT AND NEUROMODULATION FOR OVERACTIVE BLADDER

被引：1
|
作者：
Akman, R. Yavuz [1 ]
机构：
[1] Baskent Univ, Baskent Univ Istanbul Hastanesi, Tip Fak, Urol Anabilim Dali, TR-34662 Istanbul, Turkey
来源：
TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2013年 / 10卷 / 01期
关键词：
botulinum toxin; neuromodulation; overactive bladder;
D O I：
10.5505/tjod.2013.32815
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
The overactive bladder (OAB) is a symptom complex characterized by urgency with/without urge incontinence, and often associated with frequency and nocturia. First-line therapy for OAB includes behavioral therapies and anticholinergic drugs. Although a large number of patients respond to conservative or pharmacological therapy or a combination of the two, some patients are refractory and require additional options for intervention. Botulinum toxin therapy and neuromodulation are frequently used treatment options in refractory OAB patients.
引用
收藏
页码：9 / 15
页数：7
相关论文
共 50 条
  • [31] Learning Curve of Botulinum Toxin Bladder Injection for the Treatment of Refractory Overactive Bladder
    Barba, Marta
    Lazar, Tetyana
    Cola, Alice
    Marino, Giuseppe
    Manodoro, Stefano
    Frigerio, Matteo
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2022, 14 : 1 - 7
  • [32] The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA Trial
    Hall, Evelyn
    OBSTETRICS AND GYNECOLOGY, 2017, 129 (01): : 201 - 201
  • [33] The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial
    Amundsen, Cindy L.
    Richter, Holly E.
    Menefee, Shawn
    Vasavada, Sandip
    Rahn, David D.
    Kenton, Kim
    Harvie, Heidi S.
    Wallace, Dennis
    Meikle, Susie
    CONTEMPORARY CLINICAL TRIALS, 2014, 37 (02) : 272 - 283
  • [34] LONG TERM COST EFFECTIVENESS OF BOTULINUM TOXIN A AND SACRAL NEUROMODULATION FOR PATIENTS WITH REFRACTORY OVERACTIVE BLADDER
    Harry, D.
    Roberts, S.
    Parkin, D.
    Malde, S.
    Al-Kaisy, A.
    Sahai, A.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S240 - S240
  • [35] Cost-Effectiveness Analysis of Sacral Neuromodulation and Botulinum Toxin A Treatment for Patients With Idiopathic Overactive Bladder Editorial Comment
    Penson, David F.
    JOURNAL OF UROLOGY, 2011, 186 (01): : 212 - 213
  • [36] Botulinum toxin A for idiopathic overactive bladder in women
    Hampel, Christian
    UROLOGIE, 2024, 63 (07): : 658 - 665
  • [37] Women's perspective of botulinum toxin treatment for overactive bladder symptoms
    Digesu, G. Alessandro
    Panayi, Demetri
    Hendricken, Caroline
    Camarata, Michelle
    Fernando, Ruwan
    Khullar, Vikram
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2011, 22 (04) : 425 - 431
  • [38] Analysis of voiding dysfunction following botulinum toxin - A treatment for overactive bladder
    Sahai, A.
    Sangster, P.
    Griffith, D.
    Khan, M. S.
    Fowler, C. J.
    Dasgupta, P.
    BJU INTERNATIONAL, 2007, 99 : 26 - 26
  • [39] WOMEN'S' PERSPECTIVE OF BOTULINUM TOXIN TREATMENT FOR OVERACTIVE BLADDER SYMPTOMS?
    Digesu, G. A.
    Camarata, M.
    Lee, R.
    Kundi, N.
    Fernando, R.
    Khullar, V
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 169 - 169
  • [40] Women’s perspective of botulinum toxin treatment for overactive bladder symptoms
    G. Alessandro Digesu
    Demetri Panayi
    Caroline Hendricken
    Michelle Camarata
    Ruwan Fernando
    Vikram Khullar
    International Urogynecology Journal, 2011, 22 : 425 - 431
12345